ARTICLE | Clinical News
Advanced Corneal regulatory update
October 19, 1998 7:00 AM UTC
The FDA granted fast track designation to Advanced Corneal's Vitrase enzyme injection to treat vitreous hemorrhage in the back of the eye. Vitrase is in a U.S. Phase II trial, and the company said it...